MedTrace Logo

Non-Invasive CVP Method to Standard CVP Method

NCT03705299 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-10-15

No results posted yet for this study

Summary

This is a prospective, comparative, internally controlled device study that will enroll a total of 100 adult patients that require the placement of central venous catheter and CVP monitoring to assess volume status and cardiac preload.

Conditions

  • Central Venous Pressure

Interventions

DEVICE

Non-Invasive CVP vs Standard CVP

Sponsors & Collaborators

  • NeuroDx Development

    collaborator INDUSTRY

  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Irwin Gratz, DO · The Cooper Health System

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-12
Primary Completion
2018-04-06
Completion
2018-04-06
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03705299 on ClinicalTrials.gov